A high-affinity, tryptophan-selective amino acid transport system in human macrophages

Robert L. Seymour, Vadivel Ganapathy, Andrew L. Mellor, David H. Munn

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Tryptophan catabolism via the enzyme indoleamine 2,3-dioxygenase (IDO) allows human monocyte-derived macrophages (MDM) and other APC to suppress T cell proliferation. IDO helps protect murine fetuses from rejection by the maternal immune system and can promote tolerance and immunosuppression. For tryptophan to be catabolized by IDO, it must first enter the APC via transmembrane transport. It has been shown that MDM in vitro readily deplete tryptophan present in the extracellular medium to nanomolar levels via IDO activity; yet, no currently known amino acid transport system displays high affinity and specificity sufficiently to permit efficient uptake of tryptophan at these low concentrations. Here, we provide biochemical characterization of a novel transport system with nanomolar affinity and high selectivity for tryptophan. Tryptophan transport in MDM was predominantly sodium-independent and occurred via two distinct systems: one consistent with the known system L transporter and a second system with 100-fold higher affinity for tryptophan (Km<300 nM). Competition studies showed that the high-affinity system did not correspond to any known transporter activity and displayed a marked selectivity for tryptophan over other amino acids and tryptophan analogs. This new system was expressed at low levels in fresh monocytes but underwent selective induction during MDM differentiation. In contrast, resting human T cells expressed only the conventional system L. We speculate that the high-affinity, tryptophan-specific transport system allows MDM to take up tryptophan efficiently under conditions of low substrate concentration, such as may occur during interaction between T cells and IDO-expressing APC.

Original languageEnglish (US)
Pages (from-to)1320-1327
Number of pages8
JournalJournal of Leukocyte Biology
Volume80
Issue number6
DOIs
StatePublished - Dec 1 2006

Fingerprint

Amino Acid Transport Systems
Tryptophan
Macrophages
Indoleamine-Pyrrole 2,3,-Dioxygenase
T-Lymphocytes
Amino Acid Transport System L
Immunosuppression
Monocytes
Immune System
Fetus
Sodium
Mothers
Cell Proliferation

Keywords

  • Antigen-presenting cells
  • Indoleamine 2,3-dioxygenase
  • Tolerance

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Cell Biology

Cite this

A high-affinity, tryptophan-selective amino acid transport system in human macrophages. / Seymour, Robert L.; Ganapathy, Vadivel; Mellor, Andrew L.; Munn, David H.

In: Journal of Leukocyte Biology, Vol. 80, No. 6, 01.12.2006, p. 1320-1327.

Research output: Contribution to journalArticle

Seymour, Robert L. ; Ganapathy, Vadivel ; Mellor, Andrew L. ; Munn, David H. / A high-affinity, tryptophan-selective amino acid transport system in human macrophages. In: Journal of Leukocyte Biology. 2006 ; Vol. 80, No. 6. pp. 1320-1327.
@article{498c46f5953548309469d7127517da4e,
title = "A high-affinity, tryptophan-selective amino acid transport system in human macrophages",
abstract = "Tryptophan catabolism via the enzyme indoleamine 2,3-dioxygenase (IDO) allows human monocyte-derived macrophages (MDM) and other APC to suppress T cell proliferation. IDO helps protect murine fetuses from rejection by the maternal immune system and can promote tolerance and immunosuppression. For tryptophan to be catabolized by IDO, it must first enter the APC via transmembrane transport. It has been shown that MDM in vitro readily deplete tryptophan present in the extracellular medium to nanomolar levels via IDO activity; yet, no currently known amino acid transport system displays high affinity and specificity sufficiently to permit efficient uptake of tryptophan at these low concentrations. Here, we provide biochemical characterization of a novel transport system with nanomolar affinity and high selectivity for tryptophan. Tryptophan transport in MDM was predominantly sodium-independent and occurred via two distinct systems: one consistent with the known system L transporter and a second system with 100-fold higher affinity for tryptophan (Km<300 nM). Competition studies showed that the high-affinity system did not correspond to any known transporter activity and displayed a marked selectivity for tryptophan over other amino acids and tryptophan analogs. This new system was expressed at low levels in fresh monocytes but underwent selective induction during MDM differentiation. In contrast, resting human T cells expressed only the conventional system L. We speculate that the high-affinity, tryptophan-specific transport system allows MDM to take up tryptophan efficiently under conditions of low substrate concentration, such as may occur during interaction between T cells and IDO-expressing APC.",
keywords = "Antigen-presenting cells, Indoleamine 2,3-dioxygenase, Tolerance",
author = "Seymour, {Robert L.} and Vadivel Ganapathy and Mellor, {Andrew L.} and Munn, {David H.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1189/jlb.1205727",
language = "English (US)",
volume = "80",
pages = "1320--1327",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "6",

}

TY - JOUR

T1 - A high-affinity, tryptophan-selective amino acid transport system in human macrophages

AU - Seymour, Robert L.

AU - Ganapathy, Vadivel

AU - Mellor, Andrew L.

AU - Munn, David H.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Tryptophan catabolism via the enzyme indoleamine 2,3-dioxygenase (IDO) allows human monocyte-derived macrophages (MDM) and other APC to suppress T cell proliferation. IDO helps protect murine fetuses from rejection by the maternal immune system and can promote tolerance and immunosuppression. For tryptophan to be catabolized by IDO, it must first enter the APC via transmembrane transport. It has been shown that MDM in vitro readily deplete tryptophan present in the extracellular medium to nanomolar levels via IDO activity; yet, no currently known amino acid transport system displays high affinity and specificity sufficiently to permit efficient uptake of tryptophan at these low concentrations. Here, we provide biochemical characterization of a novel transport system with nanomolar affinity and high selectivity for tryptophan. Tryptophan transport in MDM was predominantly sodium-independent and occurred via two distinct systems: one consistent with the known system L transporter and a second system with 100-fold higher affinity for tryptophan (Km<300 nM). Competition studies showed that the high-affinity system did not correspond to any known transporter activity and displayed a marked selectivity for tryptophan over other amino acids and tryptophan analogs. This new system was expressed at low levels in fresh monocytes but underwent selective induction during MDM differentiation. In contrast, resting human T cells expressed only the conventional system L. We speculate that the high-affinity, tryptophan-specific transport system allows MDM to take up tryptophan efficiently under conditions of low substrate concentration, such as may occur during interaction between T cells and IDO-expressing APC.

AB - Tryptophan catabolism via the enzyme indoleamine 2,3-dioxygenase (IDO) allows human monocyte-derived macrophages (MDM) and other APC to suppress T cell proliferation. IDO helps protect murine fetuses from rejection by the maternal immune system and can promote tolerance and immunosuppression. For tryptophan to be catabolized by IDO, it must first enter the APC via transmembrane transport. It has been shown that MDM in vitro readily deplete tryptophan present in the extracellular medium to nanomolar levels via IDO activity; yet, no currently known amino acid transport system displays high affinity and specificity sufficiently to permit efficient uptake of tryptophan at these low concentrations. Here, we provide biochemical characterization of a novel transport system with nanomolar affinity and high selectivity for tryptophan. Tryptophan transport in MDM was predominantly sodium-independent and occurred via two distinct systems: one consistent with the known system L transporter and a second system with 100-fold higher affinity for tryptophan (Km<300 nM). Competition studies showed that the high-affinity system did not correspond to any known transporter activity and displayed a marked selectivity for tryptophan over other amino acids and tryptophan analogs. This new system was expressed at low levels in fresh monocytes but underwent selective induction during MDM differentiation. In contrast, resting human T cells expressed only the conventional system L. We speculate that the high-affinity, tryptophan-specific transport system allows MDM to take up tryptophan efficiently under conditions of low substrate concentration, such as may occur during interaction between T cells and IDO-expressing APC.

KW - Antigen-presenting cells

KW - Indoleamine 2,3-dioxygenase

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=33845402200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845402200&partnerID=8YFLogxK

U2 - 10.1189/jlb.1205727

DO - 10.1189/jlb.1205727

M3 - Article

VL - 80

SP - 1320

EP - 1327

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 6

ER -